• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

Introduction to 5-Nitroisoquinoline-1-carboxylic acid (CAS No. 75795-40-3)

5-Nitroisoquinoline-1-carboxylic acid, identified by the Chemical Abstracts Service registry number CAS No. 75795-40-3, is a significant compound in the field of organic chemistry and pharmaceutical research. This heterocyclic aromatic derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The nitro group and the carboxylic acid functionality in its molecular structure contribute to its reactivity, making it a valuable intermediate in synthetic chemistry and a candidate for further exploration in drug development.

The molecular structure of 5-Nitroisoquinoline-1-carboxylic acid consists of a benzene ring fused with a pyridine ring, with a nitro substituent at the 5-position and a carboxylic acid group at the 1-position. This arrangement imparts distinct electronic and steric properties, influencing its interactions with biological targets. The presence of both electron-withdrawing and electron-donating groups makes it a versatile scaffold for designing molecules with specific pharmacological activities.

In recent years, there has been growing interest in 5-Nitroisoquinoline-1-carboxylic acid due to its potential role in the synthesis of bioactive molecules. Researchers have been exploring its derivatives as candidates for treating various diseases, including cancer, inflammation, and infectious disorders. The nitro group can be reduced to an amine, providing access to aminooxoquinolines, which have shown promise in preclinical studies as kinase inhibitors.

One of the most compelling aspects of 5-Nitroisoquinoline-1-carboxylic acid is its utility as a building block in medicinal chemistry. Its rigid aromatic core allows for modifications at multiple positions, enabling the creation of libraries of compounds with tailored properties. For instance, researchers have synthesized analogs of this compound that exhibit potent activity against bacterial enzymes, highlighting its importance in antimicrobial drug discovery.

Recent advancements in computational chemistry have further enhanced the study of 5-Nitroisoquinoline-1-carboxylic acid. Molecular modeling techniques have been employed to predict how this compound interacts with biological targets, providing insights into its mechanism of action. These studies have revealed that the nitro group plays a crucial role in binding to specific residues on the target protein, thereby modulating its activity.

The carboxylic acid moiety in 5-Nitroisoquinoline-1-carboxylic acid also contributes to its versatility. It can be used to form esters or amides, expanding the range of possible derivatives. These modifications can alter the solubility, stability, and bioavailability of the compound, making it more suitable for therapeutic applications. For example, esters derived from this compound have been investigated as prodrugs, designed to release active metabolites in vivo.

In addition to its synthetic value, 5-Nitroisoquinoline-1-carboxylic acid has been studied for its potential role in materials science. Its aromatic structure and functional groups make it a candidate for developing organic semiconductors or luminescent materials. These applications are still in the early stages of research but hold promise for future technological advancements.

The chemical reactivity of 5-Nitroisoquinoline-1-carboxylic acid allows for diverse transformations that can be exploited for drug discovery. For instance, palladium-catalyzed cross-coupling reactions have been used to introduce new substituents at strategic positions within the molecule. These reactions provide access to complex derivatives that may exhibit enhanced pharmacological properties.

Another area of interest is the exploration of 5-Nitroisoquinoline-1-carboxylic acid as an intermediate in natural product synthesis. Some bioactive compounds isolated from plants and microorganisms share structural similarities with this molecule, suggesting that it could be used to mimic or enhance their effects. This approach aligns with the growing trend toward green chemistry and sustainable drug development.

The safety profile of 5-Nitroisoquinoline-1-carboxylic acid is another important consideration in its application. While it is not classified as hazardous under standard conditions, proper handling procedures should be followed to ensure safe laboratory practices. Studies on its toxicity and environmental impact are ongoing but have not yet raised significant concerns.

In conclusion,5-Nitroisoquinoline-1-carboxylic acid (CAS No. 75795-40-3) is a multifaceted compound with broad applications in pharmaceutical research and chemical synthesis. Its unique structural features make it a valuable tool for developing new drugs and materials. As research continues to uncover new possibilities for this molecule,5-Nitroisoquinoline-1-carboxylic acid is poised to play an increasingly important role in advancing scientific knowledge and innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)